Css LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Css LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $684,012 - $935,487	47,900 New	47,900 $781,000
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $85,030 - $134,750	-5,500 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $50,257 - $98,150	-2,600 Reduced 32.1%	5,500 $127,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $100,368 - $174,127	4,100 Added 102.5%	8,100 $200,000
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $320,538 - $438,208	-8,200 Reduced 67.21%	4,000 $166,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $410,960 - $809,952	8,800 Added 258.82%	12,200 $585,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $565,695 - $1.39 Million	-11,700 Reduced 77.48%	3,400 $214,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $808,776 - $1.75 Million	14,100 Added 1410.0%	15,100 $1.87 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $129,118 - $177,012	-2,200 Reduced 68.75%	1,000 $66,000
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $451,066 - $699,944	-5,800 Reduced 64.44%	3,200 $255,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $826,470 - $1.09 Million	9,000 New	9,000 $1.01 Million
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $105,440 - $134,500	-2,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $114,020 - $237,500	2,000	2,000 $116,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.